Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
wearable cameras are next XCLL .023
FNSI just traded 38K out of nowhere with 93 shares past 10 day average. Dormant, clean, fully reporting shell. 9.26M o/s, 3.7M float. Goes months without trading, then sudden flurry. SEC filings say they are looking for r/m candidates
PACV .83 Low OS low float Someone just took over that has had a 30 million dollar co sale before. Got a few on the ask
CHAA .35 was just about to grab the 35s and someone took them. thats ok.
CHAA one more thing. I found something. One one of the recent ownership filing I believe I found a connection with SYRX a stock with a 52 week high of $18.00 pps tag. Always follow the money and connection. It was one of the officers or CEO connected to it I think
CHAA .25 I am looking at the bio of the CEO and Directors. They look like a strong group and successful at that.
Michael Lebor
CEO / Founder / Board Member
Michael Lebor was the Founder & CEO of Flower.com Inc. which became one of the largest national e-commerce sellers of online flowers & gifts. He later acquired ABC Target Store Fixtures a prominent mail order store fixture company in the US, which he subsequently merged with M. Fried Store Fixtures to create one of the largest distributors on the East Coast. Mr. Lebor is also a partner in HugeMedium, a boutique internet e-commerce consulting company. He has management and operational experience; his marketing expertise extends throughout all aspects of e-commerce, distribution and fulfillment.
E-mail: michael@chatand.com
David Rosenberg
Board Member / Founder
David has been involved in the internet space since 2002. He is an expert in Search Engine Optimization, Search Engine Marketing, Pay-Per-Click, social media marketing, affiliate and email marketing, and other online mechanisms that drive sales performance. Following a stint at B&H Photo he went to work for M. Fried Store Fixtures as the Director of E-commerce. He is also a partner at CleanYourName.com which assists its clients with protecting their name and privacy.
Steve Berger
Chief Financial Officer
Mr. Berger has recent executive finance positions including Chief Financial Officer and Chief Operating Officer of Harborview Advisors and CFO of Global/CHC Worldwide LLC, a chemical coatings company. Other executive experience includes his tenure as President of Morgan Harris & Co. where he was involved in equity trading. From 2000 to 2003, Mr. Berger was CFO of Virtual BackOffice Inc. which offered virtual secretarial services. From 1983 to 1999, Mr. Berger was the Treasurer, Controller and Chief Compliance Officer with LaBranche & Co., the parent corporation of LaBranche & Co. LLC, one of the oldest and largest specialists in equity securities listed on the New York Stock Exchange and the American Stock Exchange. Mr. Berger holds a Bachelor of Science degree in business administration with a concentration in finance from Boston University.
Phil Friedman
Board Member
Currently the Chairman and CEO of AppliedWare Technologies; also was the President, CEO and founder of Ward Media, Inc. a leader in the Education Lead Generation industry. Built Ward Media to $30 million in annual sales which was then sold to XL Marketing where he remained as President and later Chief Strategy Officer until his departure in May 2011. Mr. Friedman has previously served as the Dir. of Business Development for Silver Carrot Inc. an Internet marketing company, as a Partner and VP of Sales at New Aspect Corporation, and as VP of Operations at Modern Plastic Bags.
http://chatand.com/about-us/our-team/
CHAA .25x.50 Got some. Never know could be a promo or something going to happen. Tons owned by insiders and just raised 500k bucks. Went double from .25 already. maybe it has .75 to 1.50 potential or more
Joined you on DGI F yesterday with 175K. Hearing anything new?!
Thanks for the PM on the other one! I ran out of posts yesterday.
AXCG huge runner coming, way under valued, chart setting up perfectly http://investorshub.advfn.com/boards/read_msg.aspx?message_id=101684006
DGI F Going to be a whopper to say it mildly. People dont know what they are missing. This is going to be beyond belief.imo They will regret passing up on anything below .01 .05 will look cheap. Remember this ran to $1.70!!!!!
CNGI 0189 Grabbed starter today. Looks good for 1-2 bags at least imo
DFTC .003 Looks good for a multi bagger imo
Cool check out DGI F quickly, same thing activated and name/change merger same price range as SRRL Will try to pick up some SRRL want .005s hopefully
Here we gooooo>>> SRRL !!!!!!
AS 200M
OS 70,7M
Annual list filed !!
We are Active till>>> 4/30/2015
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=c7igtNep1T6JEpH6RyvI8g%253d%253d&nt7=0
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=c7igtNep1T6JEpH6RyvI8g%253d%253d&CorpName=STELLAR+RESOURCES+LTD.
NEFT Not sure what that 109 trade was all about... They just bought yesterday at 10 and today sell to 4? Unless that was a MM recording...
I added 0005 today >>OZON
If only I were patient enough to sit bid. I wish I could grab .000s from the ask. I would do that in heart beat
OZON 0005
Share Structure
Market Value1 $20,272 a/o Apr 15, 2014
Shares Outstanding 40,543,238 a/o Feb 06, 2006
Float Not Available
Authorized Shares 55,000,000 a/o Mar 20, 2006
SAAX Come on! Dont lower ask to 9.00, You just took away FANC's bid at 6.00!!!
NEFT 5x10 Biotech RM looks like
Rich Rainey. Mr. Rainey has over twenty years of experience in forming, capitalizing and running biotechnology companies. Mr. Rainey has been affiliated with Avax Technologies for over fifteen years during which he helped the Company raise $60 million to fund drug development. At AVAX, he oversaw the launch of clinical studies and commercial activities in United States, Europe and Australia of the Company's cancer vaccines, while overseeing manufacturing and regulatory filings for Phase I, II and III protocols. He is a Certified Public Accountant in the Commonwealth of Pennsylvania and obtained his bachelors of science in accounting from the Pennsylvania State University.
Irwin L. Zalcberg. Mr. Zalcberg graduated from University of Illinois in 1970 with a BA in finance. He worked for Merrill Lynch between 1971-1974 as an account executive and on the floor of CBOE where he represented their proprietary risk arbitrage department. From 1975-1991, Mr. Zalcberg was an independent trader on the CBOE and held a Chicago Board of Trade mini seat. In addition, Mr. Zalcberg was member of the CBOE from 1973 to 2001. Mr. Zalcberg has helped manage $500M of family money, has held and continues to hold several board positions of both public and private companies, has started dozens of companies, and has been responsible for the exits of several private and public companies with a combined transaction value of almost $2B. He is also a survivor of Non-Hodgkin's Lymphoma.
Jayesh Mehta, MD. Dr. Mehta is a hematologist with over fifteen years of experience in blood cancers. He is an internationally-known expert in myeloma and hematopoietic stem cell transplantation. Dr. Mehta is co-inventor of several US patents covering the use of growth factors in myocardial infarction and stroke. He directs the Hematopoietic Stem Cell Transplant Program at Northwestern Memorial Hospital, Chicago. Dr. Mehta received his medical training at Bombay University, and specialized training/fellowship in hematologic malignancies and stem cell transplantation at Hadassah University Hospital, Jerusalem, Israel, and The Royal Marsden Hospital, UK.
David Moss. Mr. Moss is an experienced venture capitalist having over twenty years of experience in the life sciences, resource and technology space. Mr. Moss is Chairman and CEO of Re/Active Medical LTD a company focused on the disease of aging. Mr. Moss invested, helped finance and take public Mobivity Inc. (OTCBB: MFON) and Tonix Pharmaceuticals (NASDAQ: TNXP). He was recently a director of Armada Oil, Inc. (OTCBB: AOIL) and Pegasi Energy Resources Corporation (OTCBB: PGSI) and was responsible for both companies initial capital raises and public listings. He also is an investor, largest shareholder and sits on the Board of Managers of Sorteo Games LLC and is a board observer and investor for Reliant Business Services. Mr. Moss also acquired Digital Orchid, Inc. and renamed the company Sorteo Games, LLC which had over $26 million invested prior to his purchase. He also was instrumental in the purchase and restructuring of Mirapoint Software. Mirapoint is the first appliance-based email provider serving over 120 million corporate email accounts. He served as Managing Director, Corporate Finance, for Jesup Lamont Securities, where he advised companies on corporate strategy, financings, and business development. Previously, Mr. Moss served as Managing Partner at a Seattle-based venture capital firm, The Phoenix Partners with $110 million under management where he ran their healthcare portfolio. He holds an MBA from Rice University and a B.A. in Economics from the University of California, San Diego.
John T. Norton. Dr. Norton is an expert in cancer biology with 10 years of experience in cancer drug discovery & development. Dr. Norton is a co-inventor of Numonafide, one of Panther's clinical candidates. Dr. Norton received his PhD from Northwestern and is currently pursuing his MBA from the University of San Diego.
It goes quick $5.00x10.00
Only 100 shares left to 10,000.lol
NEFT WOW That was fast. Looks like a Biotech merger with the big boys? Not sure, will see how it plays out. Needs a good FS
This Information Statement is being mailed to stockholders of record of shares of common stock, par value $0.001 per share (the "Common Stock") of NEF Enterprises, Inc. (the "Company") as of April 10, 2014 with respect to a change of the majority of directors and officers of the Company. This Information Statement is being distributed on April 11, 2014. In connection with the change of control, the Company is also changing its business. Currently, the Company operates as an U.S. Securities and Exchange Commission filing agent for companies and individuals through its 100% wholly-owned subsidiary, PubCo Reporting Services, Inc., providing EDGAR and eXtensible Business Reporting Language filings and electronic data gathering, analysis, and retrieval services. Post change in control, the Company will focus its business on the acquisition and development of small molecule therapeutics for the treatment of cancer.
On or about the week of April 14, 2014, investors Irwin L. Zalcberg, Jayesh Mehta and Rich Rainey will enter into share purchase agreements ("Purchase Agreement") with Roldis Estevez, the Company's sole executive officer and director. The Purchase Agreements with Mr. Estevez contemplate the purchase of all 1,000,000 restricted shares of the Company's Common Stock held by Mr. Estevez by Messrs. Zalcberg, Mehta and Rainey. Additionally, Messrs. Zalcberg, Mehta and Rainey and other investors will enter into Purchase Agreements with all but two of the remaining existing stockholders of record to purchase 3,637,500 of the remaining 3,662,500 issued and outstanding shares of Common Stock. In total, the Purchase Agreements contemplate the purchase of 4,637,500 of the 4,662,500 issued and outstanding shares of Common Stock in the Company (the "Transaction").
The closing of the Purchase Agreements are expected to occur ten business days after mailing of this Information Statement to the Company's stockholders of record.
In consideration of the change of ownership pursuant to the closing of the Purchase Agreements, Mr. Estevez will resign as the Company's President, CEO, CFO, Treasurer, Secretary and sole Director of the Company and will be replaced by the following persons ("Proposed Management"):
Name
Position(s)
Rich Rainey
President, CEO, CFO, Treasurer, Secretary
Irwin L. Zalcberg
Chairman of the Board
Jayesh Mehta, MD
Director
David Moss
Director
John T. Norton
Director
The resignation of Mr. Estevez and the appointment of the Proposed Management will not be effected until closing of the Purchase Agreements.
The change in the business of the Company is a result of the Company's plan to enter into licensing agreements with various entities whereby the Company will obtain exclusive rights to medications in the field of human cancers. Terms of the Licensing Agreements are still in the process of negotiation.
VOTING SECURITIES AND PRINCIPAL STOCKHOLDERS
1. Voting Securities of the Company
As of April 10, 2014, there were 4,662,500 shares of the Company's Common Stock issued and outstanding. Each share of Common Stock entitles the holder thereof to one vote on each matter that may come before a meeting of the stockholders.
2. Security Ownership of Certain Beneficial Owners and Management
The following table sets forth certain information concerning the number of shares of the Company's Common Stock owned beneficially as of April 10, 2014 by: (i) the Company's sole executive officer and director, (ii) officers and directors as a group, and (iii) any other person known by the Company to own more than five percent of the Common Stock.
Title of Class
Name and Address
of Beneficial Owner
Amount and Nature of Beneficial Ownership
Percentage of Common Stock
(1)
DIRECTORS AND OFFICERS
Common Stock
Roldis Estevez
6800 SW 40 th St. #213
Miami, FL 33155
1,000,000
(direct)
21.45%
Common Stock
All Officers and Directors as a Group (1 person)
1,000,000
21.45%
5% STOCKHOLDERS
Common Stock
Christopher Ellerbeck
6800 SW 40 th St. #213
Miami, FL 33155
1,600,000
(direct)
34.32%
Common Stock
Brian Pollard
6 Chicora Ave.
Toronto, ON M5R 1T6
300,000
(direct)
6.43%
(1) Under Rule 13d-3, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in this table does not necessarily reflect the person's actual ownership or voting power with respect to the number of shares of Common Stock actually outstanding on the date of this Information Statement. As of April 10, 2014, the Company had 4,662,500 shares of Common Stock issued and outstanding.
Upon completion of the Transaction, the following table sets forth certain information concerning the number of shares of the Company's Common Stock expected to be owned beneficially by: (i) each of the Company's directors; (ii) each of the Company's named executive officers; (iii) officers and directors as a group, and (iv) any other person known by the Company to own more than five percent of the Common Stock.
Title of Class
Name and Address
of Beneficial Owner
Amount and Nature of Beneficial Ownership
Percentage of Common Stock
(1)
DIRECTORS AND OFFICERS
Common Stock
Rich Rainey
President, CEO, CFO, Treasurer, Secretary
221 Lake Scranton Rd., Scranton, PA 18505
406,929
(direct)
8.73%
Common Stock
Irwin L. Zalcberg
1,986,555
(direct)
42.61%
Common Stock
Jayesh Mehta, MD
474 N. Lake Shore Dr. Apt. 5906, Chicago, IL 60611
678,215
(direct)
14.55%
Common Stock
David Moss
23 Larkfield, Laguna Niguel, CA 92677
180,857
(direct)
3.88%
Common Stock
John T. Norton
425 Stratford Ct., Apt. 8, Del Mar, CA 92014
0
0%
Common Stock
All Officers and Directors as a Group
2,505,444
53.74%
5% STOCKHOLDERS
Common Stock
Ryan Carpel
1071 W. 15th Street, Unit 424, Chicago, IL 60608
400,000
8.58%
Common Stock
Richard Joseph Corbin, Jr.
1961 Countryside Dr., Libertyville, IL 60048
400,000
8.58%
(1) Under Rule 13d-3, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in this table does not necessarily reflect the person's actual ownership or voting power with respect to the number of shares of Common Stock actually outstanding on the date of this Information Statement. As of April 10, 2014, the Company had 4,662,500 shares of Common Stock issued and outstanding.
3. Changes in Control
Upon completion of the Transaction as described above, there will be a change of control in the Company. In consideration of the change of ownership pursuant to the closing of the Purchase Agreements, Mr. Estevez will resign as the Company's President, CFO, CEO, Treasurer, Secretary and sole Director of the Company and will be replaced by the following Proposed Management:
Name
Position(s)
Rich Rainey
President, CEO, CFO, Treasurer, Secretary
Irwin L. Zalcberg
Chairman of the Board
Jayesh Mehta, MD
Director
David Moss
Director
John T. Norton
Director
The resignation of Mr. Estevez and the appointment of the Proposed Management will not be effected until closing of the Purchase Agreements.
DIRECTOR AND EXECUTIVE OFFICERS
The following table sets forth information regarding the Company's current executive officers and directors and the proposed executive officers and directors of the Company:
Name
Age
Positions
Roldis Estevez
(current)
33
President, CEO, CFO, Treasurer, Secretary and Director
Rich Rainey
(upon closing)
47
President, CFO, CEO, Treasurer and Secretary
Irwin L. Zalcberg
(upon closing)
65
Chairman of the Board
Jayesh Mehta, MD
(upon closing)
49
Director
David Moss
(upon closing)
44
Director
John T. Norton
(upon closing)
32
Director
Set forth below is a brief description of the background and business experience of each of the listed executive officers and directors for at least the past five years.
Roldis Estevez. On January 24, 2014, the Company's board of directors (the "Board of Directors") appointed Roldis Estevez as President, CFO, CEO and Treasurer of the Company. Mr. Estevez has served as a director of the Company and Secretary since June 1, 2012. From October 2011 to present, Mr. Estevez has been employed as a Server at the London Balans Restaurant in Miami Beach, FL. From August 2007 to October 2011 Mr. Estevez held various positions and was most recently Manager at Pasha 's restaurant in Miami, FL.
Rich Rainey. Mr. Rainey has over twenty years of experience in forming, capitalizing and running biotechnology companies. Mr. Rainey has been affiliated with Avax Technologies for over fifteen years during which he helped the Company raise $60 million to fund drug development. At AVAX, he oversaw the launch of clinical studies and commercial activities in United States, Europe and Australia of the Company's cancer vaccines, while overseeing manufacturing and regulatory filings for Phase I, II and III protocols. He is a Certified Public Accountant in the Commonwealth of Pennsylvania and obtained his bachelors of science in accounting from the Pennsylvania State University.
Irwin L. Zalcberg. Mr. Zalcberg graduated from University of Illinois in 1970 with a BA in finance. He worked for Merrill Lynch between 1971-1974 as an account executive and on the floor of CBOE where he represented their proprietary risk arbitrage department. From 1975-1991, Mr. Zalcberg was an independent trader on the CBOE and held a Chicago Board of Trade mini seat. In addition, Mr. Zalcberg was member of the CBOE from 1973 to 2001. Mr. Zalcberg has helped manage $500M of family money, has held and continues to hold several board positions of both public and private companies, has started dozens of companies, and has been responsible for the exits of several private and public companies with a combined transaction value of almost $2B. He is also a survivor of Non-Hodgkin's Lymphoma.
Jayesh Mehta, MD. Dr. Mehta is a hematologist with over fifteen years of experience in blood cancers. He is an internationally-known expert in myeloma and hematopoietic stem cell transplantation. Dr. Mehta is co-inventor of several US patents covering the use of growth factors in myocardial infarction and stroke. He directs the Hematopoietic Stem Cell Transplant Program at Northwestern Memorial Hospital, Chicago. Dr. Mehta received his medical training at Bombay University, and specialized training/fellowship in hematologic malignancies and stem cell transplantation at Hadassah University Hospital, Jerusalem, Israel, and The Royal Marsden Hospital, UK.
David Moss. Mr. Moss is an experienced venture capitalist having over twenty years of experience in the life sciences, resource and technology space. Mr. Moss is Chairman and CEO of Re/Active Medical LTD a company focused on the disease of aging. Mr. Moss invested, helped finance and take public Mobivity Inc. (OTCBB: MFON) and Tonix Pharmaceuticals (NASDAQ: TNXP). He was recently a director of Armada Oil, Inc. (OTCBB: AOIL) and Pegasi Energy Resources Corporation (OTCBB: PGSI) and was responsible for both companies initial capital raises and public listings. He also is an investor, largest shareholder and sits on the Board of Managers of Sorteo Games LLC and is a board observer and investor for Reliant Business Services. Mr. Moss also acquired Digital Orchid, Inc. and renamed the company Sorteo Games, LLC which had over $26 million invested prior to his purchase. He also was instrumental in the purchase and restructuring of Mirapoint Software. Mirapoint is the first appliance-based email provider serving over 120 million corporate email accounts. He served as Managing Director, Corporate Finance, for Jesup Lamont Securities, where he advised companies on corporate strategy, financings, and business development. Previously, Mr. Moss served as Managing Partner at a Seattle-based venture capital firm, The Phoenix Partners with $110 million under management where he ran their healthcare portfolio. He holds an MBA from Rice University and a B.A. in Economics from the University of California, San Diego.
John T. Norton. Dr. Norton is an expert in cancer biology with 10 years of experience in cancer drug discovery & development. Dr. Norton is a co-inventor of Numonafide, one of Panther's clinical candidates. Dr. Norton received his PhD from Northwestern and is currently pursuing his MBA from the University of San Diego.
LEGAL PROCEEDINGS INVOLVING DIRECTORS AND EXECUTIVE OFFICERS
The Company is not aware of any legal proceedings to which any current or prospective director, officer, affiliate of the Company, or owner of more than five percent of the Company's Common Stock (beneficially or of record) is a party adverse in interest to the Company.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Except as described above, none of the following parties has, in the last two years, had any material interest, direct or indirect, in any transaction with the Company or in any presently proposed transaction that has or will materially affect the Company:
· Any of the Company's directors or officers;
· Any person proposed as a nominee for election as a director or officer;
· Any person who beneficially owns, directly or indirectly, shares carrying more than 5% of the voting rights attached to the Company's outstanding shares of Common Stock;
· Any of the Company's promoters; and
· Any member of the immediate family (including spouse, parents, children, siblings and in-laws) of any of the foregoing persons.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires the Company 's executive officers and directors and persons who own more than 10% of a registered class of the Company 's securities (" Reporting Persons ") to file reports of ownership and changes in ownership with the SEC. Reporting Persons are required by SEC regulations to furnish the Company with copies of all forms they file pursuant to Section 16(a) . Based solely on a review of such reports received by the Company , the Company believes that, during the last fiscal year, all Reporting Persons complied with all Section 16(a) filing requirements applicable to them.
AUDIT, NOMINATING AND COMPENSATION COMMITTEES OF THE BOARD OF DIRECTORS
The Company 's Board of Directors does not have standing audit, nominating or compensation committees, committees performing similar functions, or charters for such committees. Instead, the functions that might be delegated to such committees are carried out by the Board of Directors, to the extent required. The Board of Directors believes that the cost associated with such committees has not been justified under the current circumstances.
The Board of Directors believes that its current members have sufficient knowledge and experience to fulfill the duties and obligations of an audit committee. The board has determined that each of its members is able to read and understand fundamental financial statements and has substantial business experience that results in the member's financial sophistication.
Audit Committee Financial Expert
We believe that retaining an independent director who would qualify as an "audit committee financial expert" would be overly costly and burdensome and is not warranted in our circumstances given the early stages of our development and the fact that we have not generated any material revenues to date.
DIRECTOR INDEPENDENCE
Our Common Stock is quoted on the OTC Bulletin Board inter-dealer quotation system, which does not have director independence requirements. Under NASDAQ Rule 5605(a)(2), a director is not considered to be independent if he or she is also an executive officer or employee of the corporation. The Company 's sole director, Roldis Estevez, is also the Chief Executive Officer, Chief Financial Officer, President, Secretary and Treasurer. As a result, the Company does not have any independent directors.
NOMINATION AND APPOINTMENT OF DIRECTORS
Our Board of Directors does not have a policy with regards to the consideration of any director candidates recommended by our shareholders. Given the small size of the Company, a specific nominating policy would be premature and of little assistance until our operations are at a more advanced level. In the interim, our Board of Directors has determined that it is in the best position to evaluate our Company's requirements as well as the qualifications of each candidate when the board considers a nominee for a position on our Board of Directors. If shareholders wish to recommend candidates directly to our board, they may do so by sending communications to the president of our Company at the address on the cover of this annual report.
MEETINGS OF DIRECTORS
The Board of Directors currently consists of Roldis Estevez as the sole director. The Board of Directors has held no formal meetings during the previous years ended May 31, 2013 and 2012. As our Company develops a more comprehensive Board of Directors all proceedings may be conducted by resolutions consented to in writing by all the directors and filed with the minutes of the proceedings of the directors. Such resolutions consented to in writing by the directors entitled to vote on that resolution at a meeting of the directors are, according to the Nevada General Corporate Law and our Bylaws, as valid and effective as if they had been passed at a meeting of the directors duly called and held.
SECURITY HOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS
The Company has not provided any separate process for communicating with the Board of Directors . Communications to the Board of Directors may be directed to the Company at the address and telephone number set out on the cover page to this Information Statement .
COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS
Summary Compensation Table
The following table sets forth total compensation paid to or earned by our named executive officers, as that term is defined in Item 402(m)(2) of Regulation S-K, during the fiscal years ended May 31, 2013 and 2012:
Name and
Principal
Position
Year
Salary
($)
Bonus
($)
Stock Awards
($)
Option Awards
($)
Non-Equity Incentive Plan Compensation
($)
Nonqualified Deferred Compensation
($)
All other Compensation
Total
($)
Christopher Ellerbeck(1)
2013
2012
None
None
None
None
None
None
None
None
None
None
None
None
2,000
None
2,000
None
Roldis Estevez(2)
2013
2012
None
None
None
None
None
None
None
None
None
None
None
None
1,000
None
1,000
None
(1) Mr. Ellberbeck held the positions of Director since July 13, 2011 and of President, CEO, CFO and Treasurer since July 14, 2011, until he resigned from all aforementioned positions on January 24, 2014. He also held the position of secretary from July 14, 2011 until June 1, 2012.
(2) Mr. Estevez was appointed Secretary and Director of the Company on June 1, 2012, and was appointed as President, CFO, CEO and Treasurer on January 24, 2014.
Messrs. Ellerbeck and Estevez received compensation of $2,000 and $1,000 respectively during 2013 and no compensation during 2012 from the Company. There are no current employment agreements in place, however, we have tentatively agreed to pay them management fees, based on available funds.
Outstanding Awards At Fiscal Year End
There was no outstanding equity awards at the year ended May 31, 2013.
Employment Contracts
Except as disclosed above, the Company has no employment contracts, termination of employment or change-in-control arrangements with any of the Company 's executive officers or directors.
OTHER INFORMATION
The Company is subject to the information and reporting requirements of the Exchange Act and, in accordance with that Act, files periodic reports, documents and other information with the SEC relating to its business, financial statements and other matters. These reports and other information may be inspected and are available for copying at the offices of the SEC, Room 1580, 100 F Street NE, Washington D.C. 20549 and are available on the SEC's website at www.sec.gov.
SIGNATURES
Pursuant to the requirements the Securities Exchange Act of 1934, the registrant has duly caused this Information Statement to be signed on its behalf by the undersigned, thereto duly authorized.
NEF ENTERPRISES, INC.
(Registrant)
Dated: April 14, 2014
/s/ Roldis Estevez
Roldis Estevez
President, CEO, CFO, Treasurer, Secretary and Director
(Principal Executive and Financial Officer)
CSKH 0006x0009 local runner they will run her again when time is right imo
One more day to buy. It could probably run from the dollar range post split.imo Will see.
DFTC 0021x0033 Has future runner potential, got to get in and get out quick with these types. imo Who knows, maybe has long term merger potents.
CDIF Had a very nice update. Surprised no love from it. Hope more keeps coming. Deserves to be twice this pps at least imo
Nice one thanks
BSTA has 200 on ask $7.50 --- Prior asks were 10+
BSTA NEWS
Basta Holdings Provides Corporate Update GlobeNewswire "Press Releases"
FORT LAUDERDALE, Fla. , April 10, 2014 (GLOBE NEWSWIRE) -- Basta Holdings Corp. (OTCBB:BSTA), an aviation and logistics management company, today announced that it has assumed management of revenue-generating contracts in the field of heavy helicopter long-term leasing as well as private business aviation operations.
The Company now manages revenue-generating, long-term ACMI leases of heavy rotary wing aircraft commissioned by significant government, non-government organizations (NGO), UN and commercial contractors internationally. Additionally, the Company has been hired to provide services in the field of private business aviation operations. As part of the engagement, Basta Holdings anticipates entering into long term aircraft leases, which will be used in FBO operations as well as acquiring other assets which may increase the efficiency of its FBO services. Management of Basta Holdings is in negotiations with several major aviation companies in China and elsewhere in Asia as well as Africa . The Company plans to expand its long-term heavy helicopter leasing business and establish joint ventures in the acquisition and development of maintenance, repair and overhaul (MRO) facilities and private business aircraft sales, management, charter and maintenance.
President of Basta Holdings Corp. , Jacob Gitman , Ph,D., commented, "We are very confident that our experience and reputation, earned over years of operating various successful companies in the aviation industry, will ensure a prompt start and the successful development of Basta Holdings' commercial operations."
"In fact, since the new Board of Directors has taken over the company's operations, we've already begun generating revenue and anticipate significant growth in both our existing lines of business. Basta Holdings expects to quickly develop partnerships with new customers and joint ventures due to management's skill set, assets and corporate know how when operating in the most difficult and unforgiving aviation markets of the world such as Afghanistan and Africa ," added Dr. Gitman.
"In particular, we look forward to working with several large potential partners in China , where one of our board members, Mrs. Shufen Xue , has connected our company with a major aviation industry player. Our Chinese expansion plans include addressing the enormous demand of that market for helicopter services, MRO facilities and private aviation where the Chinese government has approved long-term, specific goal-oriented programs funded with multi-billion dollar government development allotments," concluded Dr. Gitman.
About Basta Holdings Corp.
Basta Holdings Corp. provides contract procurement, business development and management services in the aviation and logistics industries. The company specializes in long-term leasing of fixed wing and rotary passenger and cargo aircrafts and private business aviation, which includes charter, maintenance, overhaul and FBO development as well as various auxiliary services.
For more information on the company, please visit
www.bastaholdings.com. Forward Looking Statements.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the Securities and Exchange Commission . The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
CONTACT: Seal Point Consulting 888-959-7095 ir@sealpointconsulting.com
Source: Basta Holdings Corp.
Cool name. Will take a look
XSNX Fri, 14 Feb 2014 21:24:46 GMT ~ XSUNX INC Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/140214/xsnx10-q.html
XSNX Fri, 21 Feb 2014 18:04:08 GMT ~ XSUNX INC Financials
read full: http://finance.yahoo.com/q/is?s=xsnx
*********************************************************
XSNX Fri, 14 Mar 2014 09:00:00 GMT ~ MoneyTV with Donald Baillargeon, 3/14
[PR Newswire] - LOS ANGELES, March 14, 2014 /PRNewswire/ -- Credit card deals, cannabis, curing heroin addiction, solar power, wood pellets, vodka; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally ...
read full: http://finance.yahoo.com/news/moneytv-donald-baillargeon-3-14-090000597.html
CPOW .01 area Monster accumulation What is happening with this one?
LTVL $2.00 Got strong feeling Some merger will come soon, possibly MJ field. OS is one of lowest on OTCQB @ 400k!!!
CATA .0009 Getting some volume. Putting .0025 pps on it in future. just my opinion
NEFT They most certainly will do a Forward SPlit no? 20 to 10 50 to 1 most likely?? Got to get me some shares before too late
CNVT 0014x0027 Extremely low market cap for a shell at 14 mil. imo On the NV SOS best place for rebirths-- > This could be reactivated any time.imo If so it would run hard.
SAAX 2x10 Forward split inevitable. Management reconsidering ratio.
ITEM 7.01
REGULATION FD DISCLOSURE.
SaaSMax, Inc.’s directors are reconsidering the split ratio for the stock split scheduled to occur on September 6, 2013. At the present time, the directors have withdrawn the Notice of Change filed with the Nevada Secretary of State and will file a new notice once the appropriate ratio is determined.
IGMB .65 asking, I am curious about this one. It has different types of MMs This type of stock is one that goes from .50 to 5.00 without anyone noticing imo
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
287
|
Created
|
01/31/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |